2017-06-05 20:30:39 UTC

AGA to Host Webinar on Gastric Cancer Research Funding Opportunities

June 6, 2017

Learn more about opportunities available through the Department of Defense research program.

When researchers think about federal funding for new programs, they most often think about NIH and CDC. However, the Department of Defense (DoD) — through the Congressionally Directed Medical Research Programs (CDMRPs) — offers research funding for many diseases, including gastric cancer.

If you’re unsure how this program works, join Donna Kimbark, PhD, program manager and technical lead for multiple programs and initiatives within DoD’s CDMRPs, for a webinar during which she will review the types of award mechanisms, congressional directives and program cycle. Dr. Kimbark will also provide a step by step explanation of the Peer Reviewed Cancer Research Program (PRCRP) application process. This webinar is co-sponsored by AGA and Debbie’s Dream Foundation: Curing Stomach Cancer.

The webinar will take place on Tuesday, June 13, 2017, from noon – 1 p.m. ET. Register now

Each year, Congress decides, as part of the annual appropriations process, how much funding to allocate to the CDMRPs and which diseases are eligible for research funding. In the recently enacted fiscal year 2017 defense spending bill, $60 million was appropriated for the PRCRP. Among the cancers that would be eligible to compete for this funding is stomach cancer.

More on Gastric Cancer

Headlines from the 2018 Gastrointestinal Cancers Symposium

Jan. 24, 2018

Novel approaches for CRC screening, new treatment options for GI cancers, and more presented at the meeting, which is co-sponsored by AGA.

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

New PPI Study on Gastric Cancer Generates Media Attention

Nov. 2, 2017

AGA provides talking points to help your patients understand the science behind the PPI study.